BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND NCOA2, TIF2, 10499, ENSG00000140396, NCoA-2, MGC138808
35 results:

  • 1. Small cell osteosarcoma versus fusion-driven round cell sarcomas of bone: retrospective clinical, radiological, pathological, and (epi)genetic comparison with clinical implications.
    Hiemcke-Jiwa LS; Sumathi VP; Baumhoer D; Smetsers SE; Haveman LM; van Noesel MM; van Langevelde K; Cleven AHG; van de Sande MAJ; Ter Horst SAJ; Kester LA; Flucke U
    Virchows Arch; 2024 Mar; 484(3):451-463. PubMed ID: 38332052
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Detection of mesenchymal chondrosarcoma in pleural effusion with immunocytochemistry and determination of HEY1::ncoa2 fusion by next-generation sequencing on cell block.
    Zhong J; Wang Q; Xie Y; Niu Z; Zhou D
    Cytopathology; 2024 Jan; 35(1):149-152. PubMed ID: 37688410
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Intraosseous Spindle Cell Rhabdomyosarcoma with
    Smith BF; Doung YC; Beckett B; Corless CL; Davis LE; Davis JL
    Cancer Invest; 2023 Sep; 41(8):704-712. PubMed ID: 37668330
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. NKX3.1 immunohistochemistry and methylome profiling in mesenchymal chondrosarcoma: additional diagnostic value for a well-defined disease?
    Glauser S; Ameline B; Andrei V; Harder D; Pauli C; Trautmann M; Hartmann W; Baumhoer D
    Pathology; 2023 Aug; 55(5):621-628. PubMed ID: 37225644
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinicopathological and Molecular Characteristics of Intraosseous Rhabdomyosarcoma Involving Head and Neck Region: A Systematic Review and Meta-Analysis.
    Sivakumar N; Sharma P; Chandra S; Gupta S; Samadi FM; Baghel S
    Pediatr Dev Pathol; 2023; 26(3):299-309. PubMed ID: 37082926
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Novel low-grade renal spindle cell neoplasm with HEY1::ncoa2 fusion that is distinct from mesenchymal chondrosarcoma.
    Miller TI; Mantilla JG; Wang W; Liu YJ; Tretiakova M
    Genes Chromosomes Cancer; 2023 Mar; 62(3):171-175. PubMed ID: 36416671
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genomic profiling identifies genes and pathways dysregulated by HEY1-ncoa2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesis.
    Qi W; Rosikiewicz W; Yin Z; Xu B; Jiang H; Wan S; Fan Y; Wu G; Wang L
    J Pathol; 2022 Aug; 257(5):579-592. PubMed ID: 35342947
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Angiofibroma of soft tissue: Current status of pathology and genetics.
    Nakayama S; Nishio J; Aoki M; Koga K; Nabeshima K; Yamamoto T
    Histol Histopathol; 2022 Aug; 37(8):717-722. PubMed ID: 35211945
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Patient-derived xenografts and in vitro model show rationale for imatinib mesylate repurposing in HEY1-ncoa2-driven mesenchymal chondrosarcoma.
    Safaric Tepes P; Segovia D; Jevtic S; Ramirez D; Lyons SK; Sordella R
    Lab Invest; 2022 Sep; 102(9):1038-1049. PubMed ID: 34837064
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Malignant Cartilage-Forming Tumors.
    Hameed M
    Surg Pathol Clin; 2021 Dec; 14(4):605-617. PubMed ID: 34742483
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. ETV6-ncoa2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells.
    Fishman H; Madiwale S; Geron I; Bari V; Van Loocke W; Kirschenbaum Y; Ganmore I; Kugler E; Rein-Gil A; Friedlander G; Schiby G; Birger Y; Strehl S; Soulier J; Knoechel B; Ferrando A; Noy-Lotan S; Nagler A; Mulloy JC; Van Vlierberghe P; Izraeli S
    Blood; 2022 Jan; 139(3):399-412. PubMed ID: 34624096
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Congenital rhabdomyosarcoma: A report from the European paediatric Soft tissue sarcoma Study Group.
    Bisogno G; Minard-Colin V; Arush MB; Daragjati J; Coppadoro B; Gallego S; Alaggio R; Smeulders N; Mudry P; Zin A; Merks JHM; Slater O
    Pediatr Blood Cancer; 2022 Feb; 69(2):e29376. PubMed ID: 34582098
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Mesenchymal chondrosarcoma in central nervous system: a clinicopathological analysis].
    Huang Q; Chen YP; Song FL; Zheng LM; Liu XY; Zhang S; Wang XF
    Zhonghua Bing Li Xue Za Zhi; 2021 Aug; 50(8):870-875. PubMed ID: 34344069
    [No Abstract]    [Full Text] [Related]  

  • 14. RREB1-MKL2 fusion in a spindle cell sinonasal sarcoma: biphenotypic sinonasal sarcoma or ectomesenchymal chondromyxoid tumor in an unusual site?
    Mechtersheimer G; Andrulis M; Delank KW; Volckmar AL; Zhang L; von Winterfeld M; Stenzinger A; R Antonescu C
    Genes Chromosomes Cancer; 2021 Aug; 60(8):565-570. PubMed ID: 33715240
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. NKX3.1 immunohistochemistry is highly specific for the diagnosis of mesenchymal chondrosarcomas: experience in the Australian population.
    Ramanayake N; Vargas AC; Talbot J; Bonar F; Wong DD; Wong D; Mahar A; Karim R; Luk PP; Selinger C; Sioson L; Gill AJ; Maclean F
    Pathology; 2021 Oct; 53(6):705-712. PubMed ID: 33640159
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Diagnostic Utility of a Custom 34-Gene Anchored Multiplex PCR-Based Next-Generation Sequencing Fusion Panel for the Diagnosis of bone and Soft Tissue Neoplasms With Identification of Novel USP6 Fusion Partners in Aneurysmal bone Cysts.
    Dermawan JK; Cheng YW; Tu ZJ; Meyer A; Habeeb O; Zou Y; Goldblum JR; Billings SD; Kilpatrick SE; Reith JD; Shurtleff SA; Farkas DH; Rubin BP; Azzato EM
    Arch Pathol Lab Med; 2021 Jul; 145(7):851-863. PubMed ID: 33147323
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. NKX3.1 immunoreactivity is not identified in mesenchymal chondrosarcoma: a 25-case cohort study.
    Chen W; Hornick JL; Fletcher CDM
    Histopathology; 2021 Jan; 78(2):334-337. PubMed ID: 32779239
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. OLIG2 Immunolabeling of Mesenchymal Chondrosarcoma: Report of 14 Cases.
    Yao K; Duan Z; Yang S; Du Z; Wang Y; Qi X
    J Neuropathol Exp Neurol; 2020 Sep; 79(9):959-965. PubMed ID: 32770197
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Cartilage tumors: morphology, genetics, and current aspects of target therapy].
    Roessner A; Smolle M; Schoeder V; Haybaeck J
    Pathologe; 2020 Mar; 41(2):143-152. PubMed ID: 32060685
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Expanding the Spectrum of Intraosseous Rhabdomyosarcoma: Correlation Between 2 Distinct Gene Fusions and Phenotype.
    Agaram NP; Zhang L; Sung YS; Cavalcanti MS; Torrence D; Wexler L; Francis G; Sommerville S; Swanson D; Dickson BC; Suurmeijer AJH; Williamson R; Antonescu CR
    Am J Surg Pathol; 2019 May; 43(5):695-702. PubMed ID: 30720533
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.